VANCOUVER, BC (May 8, 2018) – Wax-it Histology Services Inc. is pleased to announce that the Standard Council of Canada’s (SCC) annual inspection of the company’s facility, SOPs and completed studies has come to a close and GLP (Good Laboratory Practice) Accreditation for the facility has been renewed. The positive outcomes of this inspection and renewal of license assure clients that Wax-it Histology Services Inc. continues to follow the stringent GLP regulations laid out by the SCC. The company has maintained GLP standards since year 2012 when it was first recognized as a GLP facility.

“Of course, clients who require GLP standards for their studies can be confident these standards are kept. Moreover, Non-GLP studies submitted follow the same stringency in the standards and rigorous quality assurance measures; clients can be assured that all material produced in our facility is of the highest quality” Commented Dr. Aruna Somasiri, Founder & CEO of Wax-It Histology Services Inc.

An electronic copy of Wax-it Histology Services’ GLP certificate can be found on the Standards Council of Canada website.

Wax-it Histology Services Inc., a GLP-compliant histopathology laboratory with over 24 years of experience, is committed to providing consistent, high-quality histology services with quick turn-around times to the international scientific research community. Whether it is a pilot project requiring custom protocol development or a large-scale multi-timepoint drug efficacy study, each project is individually customized and undergoes the strictest of quality control measures before being presented back to you, our valuable client.

Request a Complimentary Consultation

To discuss your GLP or Non-GLP study details, contact Wax-it Histology Services via email at [email protected] or by phone at 604.822.1595 for a complimentary scientific consultation.

About Wax-it Histology Services

Wax-it Histology Services is a privately held, GLP accredited contract research organization (CRO) that provides general histopathology (paraffin and frozen), immunohistochemistry (general IHC, antibody testing/validation, cross-reactivity studies), GLP and non-GLP histopathology for preclinical toxicology studies, and resin/plastic histopathology for implantable medical devices and bone. The company works with clients within the Drug Development, Medical Device, Pharmaceutical, Government, and Academic sectors. For more information, visit www.waxitinc.com.